These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22075105)

  • 1. Moderators of antidepressant response in major depression.
    Shelton RC; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):e32. PubMed ID: 22075105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
    Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
    J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General Predictors and Moderators of Depression Remission: A VAST-D Report.
    Zisook S; Johnson GR; Tal I; Hicks P; Chen P; Davis L; Thase M; Zhao Y; Vertrees J; Mohamed S
    Am J Psychiatry; 2019 May; 176(5):348-357. PubMed ID: 30947531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report.
    Braund TA; Palmer DM; Williams LM; Harris AW
    Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
    Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
    J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.
    Smagula SF; Wallace ML; Anderson SJ; Karp JF; Lenze EJ; Mulsant BH; Butters MA; Blumberger DM; Diniz BS; Lotrich FE; Dew MA; Reynolds CF
    J Psychiatr Res; 2016 Oct; 81():112-8. PubMed ID: 27438687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
    Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
    Phillips ML; Chase HW; Sheline YI; Etkin A; Almeida JR; Deckersbach T; Trivedi MH
    Am J Psychiatry; 2015 Feb; 172(2):124-38. PubMed ID: 25640931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response.
    Dreimüller N; Lieb K; Tadić A; Engelmann J; Wollschläger D; Wagner S
    J Affect Disord; 2019 Sep; 256():524-531. PubMed ID: 31280076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of treatment outcomes in major depressive disorder.
    Dunlop BW
    Expert Rev Clin Pharmacol; 2015; 8(6):669-72. PubMed ID: 26289221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
    Pizzagalli DA; Webb CA; Dillon DG; Tenke CE; Kayser J; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello J; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH
    JAMA Psychiatry; 2018 Jun; 75(6):547-554. PubMed ID: 29641834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
    Jain FA; Hunter AM; Brooks JO; Leuchter AF
    Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require "next-step" treatments: A VAST-D report.
    Zisook S; Tal I; Weingart K; Hicks P; Davis LL; Chen P; Yoon J; Johnson GR; Vertrees JE; Rao S; Pilkinton PD; Wilcox JA; Sapra M; Iranmanesh A; Huang GD; Mohamed S
    J Affect Disord; 2016 Dec; 206():232-240. PubMed ID: 27479536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
    Chin Fatt CR; Jha MK; Cooper CM; Fonzo G; South C; Grannemann B; Carmody T; Greer TL; Kurian B; Fava M; McGrath PJ; Adams P; McInnis M; Parsey RV; Weissman M; Phillips ML; Etkin A; Trivedi MH
    Am J Psychiatry; 2020 Feb; 177(2):143-154. PubMed ID: 31537090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
    Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
    Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
    Fava M; Okame T; Matsushima Y; Perry P; Weiller E; Baker RA
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):22-30. PubMed ID: 27784751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.